Pretomanid
Back to searchMolecule Structure
Scientific Name
Pretomanid
Description of the Drug
Pretomanid is part of a three-drug regimen used for the treatment of extensively drug-resistant and multidrug-resistant pulmonary tuberculosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05154
http://www.drugbank.ca/drugs/DB05154
Brand Name(s)
Not Available
Company Owner(s)
Mylan Ireland Ltd
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2983011 |
| DrugBank | DB05154 |
| PubChem: Thomson Pharma | 14754667 |
| PubChem | 456199 |
| LINCS | LSM-45767 |
| BindingDB | 50363237 |
| EPA CompTox Dashboard | DTXSID8041163 |
| DrugCentral | 5344 |
| ChemicalBook | CB41348280 |
| Guide to Pharmacology | 11172 |
| rxnorm | PRETOMANID |
| PubChem: Drugs of the Future | 92309397 |
| ZINC | ZINC000003821675 |
